Search Results 141-150 of 14786 for alt

  1. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Alanine transaminase (ALT) >1.5x Upper Limit of Normal (ULN). Total bilirubin >1.5xULN; Participants with Gilbert's syndrome can be included with total ...

  2. Liver transplant - Doctors & Departments - Mayo Clinic

    Joo DJ, et al. Bioartificial liver support for acute liver failure. Annals of Liver Transplantation. 2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of ...

  3. Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery - Mayo Clinic

    SGPT (ALT) ≤2.5 x ULN, if subject has HCC or liver metastases ≤5 x ULN; Creatinine ≤1.5 x ULN; INR ≤1.5 x ULN. Patients receiving anti-coagulation therapy ...

  4. Liver transplant - Doctors & Departments - Mayo Clinic

    Joo DJ, et al. Bioartificial liver support for acute liver failure. Annals of Liver Transplantation. 2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of ...

  5. A Study Using Momelotinib in Transfusion-Dependent Adults with Primary Myelofibrosis, Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis - Mayo Clinic

    Aspartate aminotransferase (AST/SGOT) and alanine aminotransferase (ALT/SGPT) ≤ 3 x upper limit of normal (ULN) or AST or ALT ≤ 5 x ULN if liver is involved ...

  6. Brain tumor - Doctors and departments - Mayo Clinic

    The Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This ...

  7. A Study to Test the Addition of Nivolumab to Chemotherapy to Treat Soft Tissue Sarcoma - Mayo Clinic

    Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 2.5 x upper limit of normal (ULN). For patients with significant hepatic metastases, ALT and ...

  8. Liver transplant - Doctors & Departments - Mayo Clinic

    Joo DJ, et al. Bioartificial liver support for acute liver failure. Annals of Liver Transplantation. 2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of ...

  9. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    AST, ALT, and alkaline phosphatase ≤ 2.5 x ULN, with the following exceptions: Patients with documented liver metastases: AST and/or ALT ≤ 5 x ULN; ...

  10. Comparison of Rimegepant and Placebo for Pain in IBS - Mayo Clinic

    Although Rimegepant is rarely associated with abnormal circulating liver enzymes, we shall exclude patients with baseline AST or ALT equal to or greater than ...